Logo 6 a1e69dad97a22b9caa5aa6c606f6ea7f9e9b8c4d0352141ae8a7e9bed5512ee3
  • Antibodies
  • Assays/Kits
  • Proteins/Peptides
  • siRNAs/Functional Genomics
  • Biochemicals
  • cDNA Clones
  • Cell/Tissue/Blood Products
  • Genes
  • Images

SR 140333

Name SR 140333
Supplier R&D Systems
Catalog 4012
Prices $255.00, $1,045.00
Sizes 10 mg, 50 mg
Cas Number 153050-21-6
Chemical Name 1-[2-[(3S)-3-(3,4-Dichlorophenyl)-1-[2-[3-(1-methylethoxy)phenyl]acetyl]-3-piperidinyl]ethyl]-4-phenyl-1-azoniabicyclo[2.2.2]octanechloride
Formula C37H45Cl3N2O2
Molecular Weight 656.12
Purity >97%
Supplier Page Shop

Product References

Inhibition by SR 140333 of NK1 tachykinin receptor-evoked, nitric oxide-dependent - Inhibition by SR 140333 of NK1 tachykinin receptor-evoked, nitric oxide-dependent

Hall JM, Brain SD. Br J Pharmacol. 1994 Oct;113(2):522-6.

Ava[L-Pro9,N-MeLeu10] substance P(7-11) (GR 73632) and Sar9, Met(O2)11 increase - Ava[L-Pro9,N-MeLeu10] substance P(7-11) (GR 73632) and Sar9, Met(O2)11 increase

Nieuwmeyer F, Ye J, Huizinga JD. J Pharmacol Exp Ther. 2006 Apr;317(1):439-45. Epub 2005 Dec 5.

SR 140333, a novel, selective, and potent nonpeptide antagonist of the NK1 - SR 140333, a novel, selective, and potent nonpeptide antagonist of the NK1

Oury-Donat F, Lefevre IA, Thurneyssen O, Gauthier T, Bordey A, Feltz P, Emonds-Alt X, Le Fur G, Soubrie P. J Neurochem. 1994 Apr;62(4):1399-407.

In vitro and in vivo biological activities of SR140333, a novel potent - In vitro and in vivo biological activities of SR140333, a novel potent

Emonds-Alt X, Doutremepuich JD, Heaulme M, Neliat G, Santucci V, Steinberg R, Vilain P, Bichon D, Ducoux JP, Proietto V, et al.. Eur J Pharmacol. 1993 Dec 21;250(3):403-13.



Privacy
Terms
About us
Contact us

Copyright© 2025. All Rights Reserved